Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Megan Grundy, Constantin Coussios & Robert Carlisle. (2016) Advances in systemic delivery of anti-cancer agents for the treatment of metastatic cancer. Expert Opinion on Drug Delivery 13:7, pages 999-1013.
Read now
Read now
Despina Fotiou, Grigoris Gerotziafas, Efstathios Kastritis, Meletios A. Dimopoulos & Evangelos Terpos. (2016) A review of the venous thrombotic issues associated with multiple myeloma. Expert Review of Hematology 9:7, pages 695-706.
Read now
Read now
Yvonne Mary Papamerkouriou, Eustathios Kenanidis, Zakareya Gamie, Kyriakos Papavasiliou, Thomas Kostakos, Michael Potoupnis, Ioannis Sarris, Eleftherios Tsiridis & John Kyrkos. (2015) Treatment of multiple myeloma bone disease: experimental and clinical data. Expert Opinion on Biological Therapy 15:2, pages 213-230.
Read now
Read now
Claudia Andreu-Vieyra & James R Berenson. (2014) Carfilzomib in multiple myeloma. Expert Opinion on Biological Therapy 14:11, pages 1685-1699.
Read now
Read now
Articles from other publishers (41)
Witold Prejzner, Oliwia Piekoś, Karolina Bełdzińska, Alicja Sadowska-Klasa, Ewa Zarzycka, Maria Bieniaszewska, Krzysztof Lewandowski & Jan Maciej Zaucha. (2023) The role of daratumumab in relapsed/refractory CD38 positive acute leukemias—case report on three cases with a literature review. Frontiers in Oncology 13.
Crossref
Crossref
Xu Wang, Xinfang Yu, Wei Li, Praveen Neeli, Ming Liu, Ling Li, Mingzhi Zhang, Xiaosheng Fang, Ken H. Young & Yong Li. (2022) Expanding anti-CD38 immunotherapy for lymphoid malignancies. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Alessandro Camponeschi, Kathrin Kläsener, Timothy Sundell, Christina Lundqvist, Paul T. Manna, Negar Ayoubzadeh, Martina Sundqvist, Katrin Thorarinsdottir, Mariele Gatto, Marcella Visentini, Karin Önnheim, Alaitz Aranburu, Huamei Forsman, Olov Ekwall, Linda Fogelstrand, Inger Gjertsson, Michael Reth & Inga-Lill Mårtensson. (2022) Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells. Journal of Experimental Medicine 219:9.
Crossref
Crossref
Haley Newman & David T. Teachey. (2022) A Bright Horizon: Immunotherapy for Pediatric T-Cell Malignancies. International Journal of Molecular Sciences 23:15, pages 8600.
Crossref
Crossref
Debdatta Saha & T. M. Vasuprada. (2021) Understanding the Trade-offs in Drug Development: Retrospective on Lessons from the Early Phase of the COVID-19 Pandemic. Journal of Developing Societies 37:3, pages 329-362.
Crossref
Crossref
Margaux Lejeune, Elodie Duray, Matthias Peipp, Béatrice Clémenceau, Frédéric Baron, Yves Beguin & Jo Caers. (2021) Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma. Cancers 13:12, pages 3072.
Crossref
Crossref
Yanli Li, Rui Yang, Limo Chen & Sufang Wu. (2020) CD38 as an immunomodulator in cancer. Future Oncology 16:34, pages 2853-2861.
Crossref
Crossref
Hiroko Ishiwata-Endo, Jiro Kato, Linda A. Stevens & Joel Moss. (2020) ARH1 in Health and Disease. Cancers 12:2, pages 479.
Crossref
Crossref
Ajai Chari, Sagar Lonial, Tomer M. Mark, Amrita Y. Krishnan, Keith E. Stockerl-Goldstein, Saad Z. Usmani, Anil Londhe, Delores Etheredge, Sarah Fleming, Baolian Liu, Jon Ukropec, Thomas S. Lin, Sundar Jagannath & Ajay K. Nooka. (2018) Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma. Cancer 124:22, pages 4342-4349.
Crossref
Crossref
Sara Gandolfi, Claudia Paba Prada & Paul G. Richardson. (2018) How I treat the young patient with multiple myeloma. Blood 132:11, pages 1114-1124.
Crossref
Crossref
Kimaya Reddy, Myo Htut, Amrita Krishnan & Sanjeet S. Dadwal. (2018) Aseptic Meningitis as a Complication of Daratumumab Therapy. Clinical Lymphoma Myeloma and Leukemia 18:8, pages e333-e335.
Crossref
Crossref
Prashant R. Tembhare, Sitaram Ghogale, Wilma Tauro, Yajamanam Badrinath, Nilesh Deshpande, Shweta Kedia, Keziah Cherian, Nikhil V. Patkar, Gaurav Chatterjee, Sumeet Gujral & Papagudi G. Subramanian. (2018) Evaluation of CD229 as a new alternative plasma cell gating marker in the flow cytometric immunophenotyping of monoclonal gammopathies. Cytometry Part B: Clinical Cytometry 94:3, pages 509-519.
Crossref
Crossref
Tatiana A. Karakasheva, George A. Dominguez, Ayumi Hashimoto, Eric W. Lin, Christopher Chiu, Kate Sasser, Jae W. Lee, Gregory L. Beatty, Dmitry I. Gabrilovich & Anil K. Rustgi. (2018) CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients. JCI Insight 3:6.
Crossref
Crossref
Xiangning Bu, Jiro Kato, Julie A Hong, Maria J Merino, David S Schrump, Frances E Lund & Joel Moss. (2018) CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells. Carcinogenesis 39:2, pages 242-251.
Crossref
Crossref
Charise Gleason & Donna D. Catamero. (2017) Immunotherapy in Multiple Myeloma. Seminars in Oncology Nursing 33:3, pages 292-298.
Crossref
Crossref
. (2017) Drug Combinations with Transplantation for Myeloma. New England Journal of Medicine 377:1, pages 91-94.
Crossref
Crossref
Deepak A. Deshpande, Alonso G.P. Guedes, Frances E. Lund, Subbaya Subramanian, Timothy F. Walseth & Mathur S. Kannan. (2017) CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets. Pharmacology & Therapeutics 172, pages 116-126.
Crossref
Crossref
Tetsumi Yoshida, Keichiro Mihara, Yoshifumi Takei, Kazuyoshi Yanagihara, Takanori Kubo, Joyeeta Bhattacharyya, Chihaya Imai, Tatsuji Mino, Yoshihiro Takihara & Tatsuo Ichinohe. (2016) All-trans retinoic acid enhances cytotoxic effect of T cells with an anti-CD38 chimeric antigen receptor in acute myeloid leukemia. Clinical & Translational Immunology 5:12, pages e116.
Crossref
Crossref
Michael Boyiadzis, Michael R. Bishop, Rafat Abonour, Kenneth C. Anderson, Stephen M. Ansell, David Avigan, Lisa Barbarotta, Austin John Barrett, Koen Van Besien, P. Leif Bergsagel, Ivan Borrello, Joshua Brody, Jill Brufsky, Mitchell Cairo, Ajai Chari, Adam Cohen, Jorge Cortes, Stephen J. Forman, Jonathan W. Friedberg, Ephraim J. Fuchs, Steven D. Gore, Sundar Jagannath, Brad S. Kahl, Justin Kline, James N. Kochenderfer, Larry W. Kwak, Ronald Levy, Marcos de Lima, Mark R. Litzow, Anuj Mahindra, Jeffrey Miller, Nikhil C. Munshi, Robert Z. Orlowski, John M. Pagel, David L. Porter, Stephen J. Russell, Karl Schwartz, Margaret A. Shipp, David Siegel, Richard M. Stone, Martin S. Tallman, John M. Timmerman, Frits Van Rhee, Edmund K. Waller, Ann Welsh, Michael Werner, Peter H. Wiernik & Madhav V. Dhodapkar. (2016) The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia. Journal for ImmunoTherapy of Cancer 4:1.
Crossref
Crossref
Noopur S. Raje, Edward A. FaberJrJr, Paul G. Richardson, Gary Schiller, Raymond J. Hohl, Adam D. Cohen, Andres Forero, Susan Carpenter, Tuan S. Nguyen, Ilaria Conti, Christopher J. Kaiser, Damien M. Cronier, James E. Wooldridge & Kenneth C. Anderson. (2016) Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma. Clinical Cancer Research 22:23, pages 5688-5695.
Crossref
Crossref
John R Mills, Mindy C Kohlhagen, Surendra Dasari, Patrick M Vanderboom, Robert A Kyle, Jerry A Katzmann, Maria A V Willrich, David R Barnidge, Angela Dispenzieri & David L Murray. (2016) Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry. Clinical Chemistry 62:10, pages 1334-1344.
Crossref
Crossref
Aneta SchieferdeckerAnna OberleBenjamin ThieleFabian HofmannMarkus GöthelSebastian MietheMichael HustFriederike BraigMareike VoigtUte-Marie von PeinFriedrich Koch-Nolte, Friedrich Haag, Malik Alawi, Daniela Indenbirken, Adam Grundhoff, Carsten BokemeyerUlrike Bacher, Nicolaus KrögerMascha Binder. (2016) A transplant “immunome” screening platform defines a targetable epitope fingerprint of multiple myeloma. Blood 127:25, pages 3202-3214.
Crossref
Crossref
Philippe Moreau, Niels W. C. J. van de Donk, Jesus San Miguel, Henk Lokhorst, Hareth Nahi, Dina Ben-Yehuda, Michele Cavo, Gordon Cook, Michel Delforge, Hermann Einsele, Sonja Zweegman, Heinz Ludwig, Christoph Driessen, Antonio Palumbo, Thierry Facon, Torben Plesner, Meletios Dimopoulos, Pia Sondergeld, Pieter Sonneveld & María-Victoria Mateos. (2016) Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma. Drugs 76:8, pages 853-867.
Crossref
Crossref
Paul G. Richardson. (2016) The Future of Myeloma Therapy: One Size Does Not Fit All. Journal of Oncology Practice 12:4, pages 295-296.
Crossref
Crossref
Camille Guillerey, Kyohei Nakamura, Slavica Vuckovic, Geoffrey R. Hill & Mark J. Smyth. (2016) Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies. Cellular and Molecular Life Sciences 73:8, pages 1569-1589.
Crossref
Crossref
S Lonial, B Durie, A Palumbo & J San-Miguel. (2015) Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives. Leukemia 30:3, pages 526-535.
Crossref
Crossref
Tomas Jelinek & Roman Hajek. (2016) Monoclonal antibodies — A new era in the treatment of multiple myeloma. Blood Reviews 30:2, pages 101-110.
Crossref
Crossref
H Jiang, C Acharya, G An, M Zhong, X Feng, L Wang, N Dasilva, Z Song, G Yang, F Adrian, L Qiu, P Richardson, N C Munshi, Y-T Tai & K C Anderson. (2015) SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide. Leukemia 30:2, pages 399-408.
Crossref
Crossref
Kenneth C. Anderson. 2016. Plasma Cell Dyscrasias. Plasma Cell Dyscrasias
15
22
.
Rebecca Karp Leaf, Hearn Jay Cho & David Avigan. (2015) Immunotherapy for Multiple Myeloma, Past, Present, and Future: Monoclonal Antibodies, Vaccines, and Cellular Therapies. Current Hematologic Malignancy Reports 10:4, pages 395-404.
Crossref
Crossref
Yu-Tzu Tai & Kenneth C Anderson. (2015) Targeting B-cell maturation antigen in multiple myeloma. Immunotherapy 7:11, pages 1187-1199.
Crossref
Crossref
Tatiana A. Karakasheva, Todd J. Waldron, Evgeniy Eruslanov, Sang-Bae Kim, Ju-Seog Lee, Shaun O'Brien, Philip D. Hicks, Devraj Basu, Sunil Singhal, Fabio Malavasi & Anil K. Rustgi. (2015) CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer. Cancer Research 75:19, pages 4074-4085.
Crossref
Crossref
I S Nijhof, R W J Groen, H M Lokhorst, B van Kessel, A C Bloem, J van Velzen, R de Jong-Korlaar, H Yuan, W A Noort, S K Klein, A C M Martens, P Doshi, K Sasser, T Mutis & N W C J van de Donk. (2015) Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab. Leukemia 29:10, pages 2039-2049.
Crossref
Crossref
Giada Bianchi, Paul G. Richardson & Kenneth C. Anderson. (2015) Promising therapies in multiple myeloma. Blood 126:3, pages 300-310.
Crossref
Crossref
Jacob P. Laubach & Paul G. Richardson. (2015) CD38-Targeted Immunochemotherapy in Refractory Multiple Myeloma: A New Horizon. Clinical Cancer Research 21:12, pages 2660-2662.
Crossref
Crossref
Markus Hansson, Peter Gimsing, Ashraf Badros, Titti Martinsson Niskanen, Hareth Nahi, Fritz Offner, Morten Salomo, Elisabeth Sonesson, Morten Mau-Sorensen, Yvonne Stenberg, Annika Sundberg, Ingrid Teige, Jan Van Droogenbroeck, Stina Wichert, Maurizio Zangari, Björn Frendeus, Magnus Korsgren, Martine Poelman & Guido Tricot. (2015) A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma. Clinical Cancer Research 21:12, pages 2730-2736.
Crossref
Crossref
John R. Mills, David R. Barnidge & David L. Murray. (2015) Detecting monoclonal immunoglobulins in human serum using mass spectrometry. Methods 81, pages 56-65.
Crossref
Crossref
Aneel Paulus, Kasyapa S. Chitta, Paul K. Wallace, Pooja P. Advani, Sharoon Akhtar, Maja Kuranz-Blake, Sikander Ailawadhi & Asher A. Chanan-Khan. (2015) Immunophenotyping of Waldenströms Macroglobulinemia Cell Lines Reveals Distinct Patterns of Surface Antigen Expression: Potential Biological and Therapeutic Implications. PLOS ONE 10:4, pages e0122338.
Crossref
Crossref
Valeria Quarona, Valentina Ferri, Antonella Chillemi, Marina Bolzoni, Cristina Mancini, Gianluca Zaccarello, Ilaria Roato, Fabio Morandi, Danilo Marimpietri, Giuliano Faccani, Eugenia Martella, Vito Pistoia, Nicola Giuliani, Alberto L. Horenstein & Fabio Malavasi. (2015) Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche. Annals of the New York Academy of Sciences 1335:1, pages 10-22.
Crossref
Crossref
Nathan G. Dolloff. 2015.
191
226
.
Maria M. Picken & Kevin Barton. 2015. Amyloid and Related Disorders. Amyloid and Related Disorders
489
505
.